| Exploring the multifocal role of phytochemicals as immunomodulators T Behl, K Kumar, C Brisc, M Rus, DC Nistor-Cseppento, C Bustea, ... Biomedicine & Pharmacotherapy 133, 110959, 2021 | 146 | 2021 |
| Recognizing the benefits of pre-/probiotics in metabolic syndrome and type 2 diabetes mellitus considering the influence of akkermansia muciniphila as a key gut bacterium RA Corb Aron, A Abid, CM Vesa, AC Nechifor, T Behl, TC Ghitea, ... Microorganisms 9 (3), 618, 2021 | 125 | 2021 |
| Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors CM Vesa, L Popa, AR Popa, M Rus, AA Zaha, S Bungau, DM Tit, ... Diagnostics 10 (5), 314, 2020 | 90 | 2020 |
| Risk factors for adiposity in the urban population and influence on the prevalence of overweight and obesity AR Popa, O Fratila, M Rus, RAC Aron, CM Vesa, C Pantis, CC Diaconu, ... Experimental and therapeutic medicine 20 (1), 129-133, 2020 | 49 | 2020 |
| Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD S Bungau, T Behl, DM Tit, F Banica, OG Bratu, CC Diaconu, ... Experimental and therapeutic medicine 20 (6), 1-1, 2020 | 45 | 2020 |
| Chemically Diverse and Biologically Active Secondary Metabolites from Marine Phylum chlorophyta SAA Shah, SSU Hassan, S Bungau, Y Si, H Xu, MH Rahman, T Behl, ... Marine drugs 18 (10), 493, 2020 | 40 | 2020 |
| Exploring the genetic conception of obesity via the dual role of FoxO T Behl, I Kaur, A Sehgal, S Singh, G Zengin, N Negrut, ... International journal of molecular sciences 22 (6), 3179, 2021 | 11 | 2021 |
| Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium … RA Corb Aron, A Abid, CM Vesa, AC Nechifor, T Behl, TC Ghitea, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 9 | 2021 |
| Acute kidney injury incidence and models for mortality prediction in acute coronary syndromes M Moisi, CM Vesa, S Bungau, DM Tit, RA Corb Aron, O Bratu, ... Rom. J. Mil. Med 113, 133-140, 2020 | 4 | 2020 |
| Epidemiology and Pathophysiological Mechanisms involved in Alteration of Glomerular Function in Diabetic Patients M Stoita, A Abid, C VESA, RAC Aron, TC Ghitea, G Angelescu, A Popa Arch. Balk. Med. Union 56 (1), 2021 | 3 | 2021 |
| Effects of Probiotic Supplementation on Metabolic Syndrome Components in Type 2 Diabetes Mellitus Patients a Case-Control Study RAC Aron, DM Tit, AL Purza, A Abid, CM Vesa, G Angelescu, S Bungau Arch. Balk. Med. Union 56, 201-212, 2021 | 1 | 2021 |
| The Influence Of Dietary Interventions On Paraclinical Parameters In Patients With Metabolic Syndrome TC Ghitea, RAC Aron, L Lazar, S Bungau Arch. Balk. Med. Union 55, 592-600, 2020 | 1 | 2020 |
| Interrelationships between hyperuricemia, metabolic syndrome and chronic kidney disease in patients with diabetes mellitus A BAIDOG, S BUNGAU, T BEHL, I RATIU, RAC ARON, F URSU, L LAZAR, ... Arch Balk Med Union 55 (3), 453-461, 2020 | 1 | 2020 |
| PARTICULARITIES OF THE INTESTINAL MICROBIOME COMPOSITION IN ROMANIAN PATIENTS WITH METABOLIC SYNDROME AND TYPE 2 DIABETES RAC ARON, DM TIT, R MOLERIU, CM VESA, S BUNGAU, AG TARCE, ... | | 2021 |
